Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Operating Expenses (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Operating Expenses for 3 consecutive years, with $83.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 34.24% to $83.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $276.0 million, a 54.04% decrease, with the full-year FY2025 number at $276.0 million, down 54.04% from a year prior.
  • Operating Expenses was $83.9 million for Q4 2025 at Nuvation Bio, up from $66.2 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $470.5 million in Q2 2024 to a low of $20.2 million in Q1 2024.
  • A 3-year average of $81.4 million and a median of $53.7 million in 2024 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: skyrocketed 1700.44% in 2024, then crashed 86.0% in 2025.
  • Nuvation Bio's Operating Expenses stood at $20.8 million in 2023, then skyrocketed by 200.11% to $62.5 million in 2024, then skyrocketed by 34.24% to $83.9 million in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Operating Expenses are $83.9 million (Q4 2025), $66.2 million (Q3 2025), and $65.8 million (Q2 2025).